Provided by Tiger Fintech (Singapore) Pte. Ltd.

XILIO THERAPEUTICS, INC.

0.8364
+0.02242.75%
Volume:180.78K
Turnover:152.16K
Market Cap:43.30M
PE:-0.77
High:0.8600
Open:0.8305
Low:0.8274
Close:0.8140
Loading ...

Xilio Therapeutics Reports 2024 Financial Results and Pipeline Progress

TIPRANKS
·
12 Mar

BRIEF-Xilio Therapeutics May Offer, Sell Shares Of Common Stock Of Up To $50 Million From Time To Time

Reuters
·
11 Mar

Xilio Therapeutics files $250M mixed securities shelf

TIPRANKS
·
11 Mar

Xilio Therapeutics Inc Files for Mixed Shelf of up to $250 Mln- SEC Filing

THOMSON REUTERS
·
11 Mar

Xilio Therapeutics, Inc. (XLO) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
11 Mar

Xilio Therapeutics Q4 2024 GAAP EPS $(0.20) Beats $(0.21) Estimate, Xilio Anticipates That Its Cash And Cash Equivalents Of $55.3M As Of December 31, 2024, Together With The $52M Upfront Payments Received From AbbVie Is Expected To Provide Cash Runway Into Q1 Of 2026

Benzinga
·
11 Mar

Press Release: Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2024 Financial Results

Dow Jones
·
11 Mar

BRIEF-Abbvie Inc. Reports 9.0 % Passive Stake In Xilio Therapeutics, Inc. As Of Feb 11 - SEC Filing

Reuters
·
19 Feb

Pharma Stock Roundup: NVS, ABBV M&A Deals, FDA Nod to RHHBY, PFE Drugs

Zacks
·
14 Feb

Analysts Offer Insights on Healthcare Companies: Ocugen (OCGN) and Xilio Therapeutics (XLO)

TIPRANKS
·
13 Feb

Xilio (XLO) Stock Zooms 125% Higher On Cancer Fighting Deal with AbbVie

TIPRANKS
·
13 Feb

Crude Oil Down Over 2%; Upstart Shares Jump Following Earnings

Benzinga
·
13 Feb

Why Is Nano-Cap Cancer-Focused Xilio Therapeutics Stock Trading Over 100% On Wednesday?

Benzinga
·
12 Feb

Xilio Therapeutics Shares up 107% After Collaboration With Abbvie to Develop Cancer Treatments

THOMSON REUTERS
·
12 Feb

Xilio Therapeutics Shares Surge Premarket on AbbVie Deal

Dow Jones
·
12 Feb

AbbVie, Xilio Collaborate on Tumor-Activated Immunotherapies

MT Newswires Live
·
12 Feb

BUZZ-Xilio jumps after collaboration with AbbVie to develop cancer treatments

Reuters
·
12 Feb

Xilio Therapeutics Partners with AbbVie for Immunotherapy Expansion

TIPRANKS
·
12 Feb

AbbVie, Xilio Therapeutics Set Collaboration, Option-To-License Agreement

Dow Jones
·
12 Feb

BRIEF-Abbvie And Xilio Therapeutics Announce Collaboration

Reuters
·
12 Feb